|

MARCH 11, 2015

Davis Polk, Mayer Brown represents Abbott Laboratories on $2.5 billion note offering

Mayer Brown guided Chicago-based Abbott Laboratories in its multi-tiered note offering of $2.5 billion worth of senior notes. The company sold $750 million worth of senior notes with a 2 percent interest rate due 2020 and another $750 million worth of senior notes with a 2.55 percent interest rate due 2022. Abbott also sold $1 billion worth of senior notes with a 2.95 percent interest rate due 2025.

Mayer Brown used a Chicago-based team that included partners Philip Niehoff and James Barry and associates James Lisak and Nicole Puza.